Literature DB >> 4100015

Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

J E McLaughlin, D S Reeves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4100015     DOI: 10.1016/s0140-6736(71)91001-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.

Authors:  G R Aronoff; R A Brier; R S Sloan; M E Brier
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 3.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Interactions of carbenicillin and ticarcillin with gentamicin.

Authors:  M Davies; J R Morgan; C Anand
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

5.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.

Authors:  C E Halstenson; C A Hirata; K L Heim-Duthoy; P A Abraham; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

7.  Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods.

Authors:  S C Ebert; J H Jorgensen; D J Drutz; W A Clementi
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

8.  Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.

Authors:  D C Blair; D O Duggan; E T Schroeder
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 9.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

10.  Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

Authors:  R L Girolami; J M Stamm
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.